Clinical Trial

Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics

Name: Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics — clinical trial record (NCT07399210)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SHC2408

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this observational study is to learn if cfDNA fragmentomics can noninvasively diagnose whether lung nodules are benign or malignant in adults with imaging-detected lung nodules.

Trial Details

NCT Number	NCT07399210
Lead Sponsor	Baohui Han
Conditions	Lung Cancer (Diagnosis), Fragmentomics
Enrollment	240 participants
Start Date	2024-08-21
Primary Completion	2026-08-21 (estimated)
Study Completion	2026-08-21 (estimated)
Updated on ClinicalTrials.gov	2026-02-10